Lutronic Infini and LaseMD Systems in Combination Treatment

Exclusion Criteria

• •1. Presence of an active systemic or local skin disease that may affect wound healing.
• •2. History of keloids or poor wound healing.
• •3. Severe solar elastosis.
• •4. Excessive subcutaneous fat in the area(s) to be treated.
• •5. Excessive skin laxity on the area(s) to be treated.
• •6. Significant scarring in the area(s) to be treated that would interfere with assessing results.
• •7. Open wounds or lesions in the area(s) to be treated.
• •8. Inability to understand the protocol or to give informed consent.
• •9. Microdermabrasion, or prescription level glycolic acid treatment to the treatment area(s) within four weeks prior to study participation or during the study.
• •10. Excessive dermatochalasis, deep dermal scarring, or thick sebaceous skin in the area(s) to be treated.
• •11. BMI equal to or greater than 30.
• •12. History of chronic drug or alcohol abuse.
• •13. History of collagen vascular disease.
• •14. History of autoimmune disease.
• •15. Subjects with implanted pacemaker or defibrillator.
• •16. Subjects with sensitivity or allergy to gold.
• •17. Subjects with sensitivity or allergy to pre-treatment medication.
• •18. Subjects with photosensitive skin.
• •19. Concurrent therapy that, in the investigator's opinion, would interfere with the evaluation of the safety or efficacy of the study device.
• •20. Subjects who anticipate the need for inpatient surgery or overnight hospitalization during the study.
• •21. Subjects who, in the investigator's opinion, have a history of poor cooperation, noncompliance with medical treatment, or unreliability.
• •22. Concurrent enrollment in any study involving the use of investigational devices or drugs.
• •23. Current smoker or history of smoking in the last five years.
• •24. Current user of any nicotine-containing products, e.g., e-cigarettes, Nicorette gum, nicotine patches, etc.
• •25. History of surgical or cosmetic treatments in the area(s) to be treated within the past year.
• •26. History or current use of the following prescription medications:
• •1. Accutane or other systemic retinoids within the past twelve months;
• •2. Topical Retinoids within the past two weeks; and/or
• •3. Antiplatelet agents/Anticoagulants (Coumadin, Heparin, Plavix) within the past two weeks.
• •27. Psychiatric drugs that in the investigators opinion would impair the subject from understanding the protocol requirements or understanding and signing the informed consent.